CAPHA: Central Auditory Processing and the Use of Hearing Aids

Sponsor
Jong Woo Chung (Other)
Overall Status
Completed
CT.gov ID
NCT01897181
Collaborator
(none)
27
1
2
29
0.9

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the central auditory processing in patients with bilateral sensorineural hearing loss and to observe the change of the central auditory processing ability after using hearing aids.

Condition or Disease Intervention/Treatment Phase
  • Device: Hearing aids
N/A

Detailed Description

Screening for recruiting

  • Among patients who are visiting for hearing disturbance, patients with bilateral sensorineural hearing loss will be included after audiologic tests, history taking and physical examination.

  • audiologic tests: pure tone audiometry, speech audiometry, impedence audiometry, distortion product otoacoustic emission, auditory brainstem response.

Dividing into "Hearing aids" group and "No hearing aids" group

  • The use of hearing aids will be recommended to all included patients.

  • Hearing aids group: patients who want to be prescribed hearing aids (28 subjects)

  • No hearing aids group: patients who do not want to be prescribed hearing aids (28 subjects)

Audiologic test

  • Hearing in noise test (HINT), central auditory processing disorder test

  • at screening, 1, 3, 6, 9 and 12 months after starting hearing aids use

Study Design

Study Type:
Interventional
Actual Enrollment :
27 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of the Central Auditory Processing in Patients (Elder Than 45 Years Old) With Bilateral Sensorineural Hearing Loss and the Change of the Central Auditory Processing Ability by the Use of Hearing Aids (CAPHA)
Study Start Date :
Jul 1, 2013
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Hearing aids

Patients who agree to use hearing aids

Device: Hearing aids
Using hearing aids for 12 months

No Intervention: No hearing aids

Patients who did not agree to use hearing aids

Outcome Measures

Primary Outcome Measures

  1. Change from the baseline in the Hearing In Noise Test (HINT) score at 6 months [at screening and 6 months after starting hearing aids use]

    HINT measures a person's ability to hear speech in quiet and in noise. In the test, the patient is required to repeat sentences both in a quiet environment and with competing noise being presented from different directions.

Secondary Outcome Measures

  1. changes from the baseline in central auditory processing disorder test score at 1, 3, 6, 9 and 12 months [at screening, 1, 3, 6, 9, and 12 months after starting hearing aids use]

    The central auditory processing disorder test is composed of three subtests; duration pattern test, frequency pattern test and dichotic words test. The patient is required to discriminate long duration sound from short one and high frequency sound from low one, and to repeat two words that are given simultaneously.

  2. changes from the baseline in the HINT score at 3, 9, and 12 months [baseline, 3, 9 and 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults of age 45 years of older

  • Bilateral sensorineural hearing loss

  • Average pure tone audiometry threshold >= 40dB

  • Speech discrimination >= 60% in both ears

Exclusion Criteria:
  • Refusing the study

  • Medical history of any brain damage or intracranial surgery

  • Showing signs of central lesion in MRI or neurologic exams

  • Speech discrimination < 60% in any ear

Contacts and Locations

Locations

Site City State Country Postal Code
1 Asan Medical Center Seoul Korea, Republic of 138-736

Sponsors and Collaborators

  • Jong Woo Chung

Investigators

  • Study Chair: Jong Woo Chung, MD, Asan Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jong Woo Chung, MD, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01897181
Other Study ID Numbers:
  • AMC-2013-0455
First Posted:
Jul 11, 2013
Last Update Posted:
Feb 17, 2016
Last Verified:
Feb 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Jong Woo Chung, MD, Asan Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2016